Peginterferon alfa-2b plus weight-based ribavirin for 24 weeks in patients with chronic hepatitis C virus genotype 1 with low viral load who achieve rapid viral response. [electronic resource]
Producer: 20120504Description: e120-5 p. digitalISSN:- 1365-2893
- Adolescent
- Adult
- Antiviral Agents -- administration & dosage
- Female
- Genotype
- Hepacivirus -- classification
- Hepatitis C, Chronic -- drug therapy
- Humans
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Male
- Middle Aged
- Polyethylene Glycols -- administration & dosage
- Recombinant Proteins -- administration & dosage
- Recurrence
- Ribavirin -- administration & dosage
- Time Factors
- Treatment Outcome
- Viral Load
- Young Adult
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.